- Home
- Publications
- Publication Search
- Publication Details
Title
A review of paliperidone palmitate
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume 12, Issue 12, Pages 1383-1397
Publisher
Informa UK Limited
Online
2012-12-14
DOI
10.1586/ern.12.137
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia
- (2012) Danielle Coppola et al. BMC Psychiatry
- Long-Acting Injectable Antipsychotics for the Maintenance Treatment of Bipolar Disorder
- (2012) Alexandre Duarte Gigante et al. CNS DRUGS
- Practical guidelines on the use of paliperidone palmitate in schizophrenia
- (2012) Richard Newton et al. CURRENT MEDICAL RESEARCH AND OPINION
- Extended-Release Intramuscular Paliperidone Palmitate
- (2012) Natalie J. Carter DRUGS
- A review of olanzapine pamoate
- (2012) Pierre Chue et al. EXPERT OPINION ON PHARMACOTHERAPY
- Treatment response after relapse in a placebo-controlled maintenance trial in schizophrenia
- (2012) Robin Emsley et al. SCHIZOPHRENIA RESEARCH
- Cost effectiveness of paliperidone palmitate versus risperidone long-acting injectable and olanzapine pamoate for the treatment of patients with schizophrenia in Sweden
- (2012) Angelika Mehnert et al. JOURNAL OF MEDICAL ECONOMICS
- The threshold rate of oral atypical anti-psychotic adherence at which paliperidone palmitate is cost saving
- (2012) Natalie C. Edwards et al. JOURNAL OF MEDICAL ECONOMICS
- Anaphylactoid reaction to paliperidone palmitate extended-release injectable suspension in a patient tolerant of oral risperidone
- (2011) R. Perry et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Onset of efficacy and tolerability following the initiation dosing of long-acting paliperidone palmitate: post-hoc analyses of a randomized, double-blind clinical trial
- (2011) Cynthia A Bossie et al. BMC Psychiatry
- Cost-effectiveness of olanzapine long-acting injection in the treatment of patients with schizophrenia in the United States: a micro-simulation economic decision model
- (2011) Nicolas M. Furiak et al. CURRENT MEDICAL RESEARCH AND OPINION
- Changes in schizophrenia-related hospitalization and ER use among patients receiving paliperidone palmitate: results from a clinical trial with a 52-week open-label extension (OLE)
- (2011) Chris M. Kozma et al. CURRENT MEDICAL RESEARCH AND OPINION
- Olanzapine pamoate for the treatment of schizophrenia
- (2011) Dieter Naber EXPERT OPINION ON PHARMACOTHERAPY
- A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia
- (2011) Huafang Li et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The Pharmacokinetics of Paliperidone Versus Risperidone
- (2011) Jose de Leon et al. PSYCHOSOMATICS
- Effects of acute paliperidone palmitate treatment in subjects with schizophrenia recently treated with oral risperidone
- (2011) Jennifer Kern Sliwa et al. SCHIZOPHRENIA RESEARCH
- Oral versus depot antipsychotic drugs for schizophrenia—A critical systematic review and meta-analysis of randomised long-term trials
- (2011) Claudia Leucht et al. SCHIZOPHRENIA RESEARCH
- Risperidone long-acting injection: a review of its long term safety and efficacy
- (2011) Michael Rainer Neuropsychiatric Disease and Treatment
- Number needed to treat and number needed to harm with paliperidone palmitate relative to long-acting haloperidol, bromperidol, and fluphenazine decanoate for treatment of patients with schizophrenia
- (2011) Srihari Gopal et al. Neuropsychiatric Disease and Treatment
- Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: post hoc analysis of a randomized, double-blind clinical trial
- (2011) Larry Alphs et al. Annals of General Psychiatry
- Intramuscular Paliperidone Palmitate
- (2010) Sheridan M. Hoy et al. CNS DRUGS
- Olanzapine Long-Acting Injection
- (2010) James E. Frampton DRUGS
- Paliperidone Extended Release
- (2010) Claudine M. Chwieduk et al. DRUGS
- Paliperidone extended-release: a review of efficacy and tolerability in schizophrenia, schizoaffective disorder and bipolar mania
- (2010) Carla M Canuso et al. EXPERT OPINION ON PHARMACOTHERAPY
- Efficacy and safety of paliperidone palmitate in adult patients with acutely symptomatic schizophrenia: a randomized, double-blind, placebo-controlled, dose-response study
- (2010) Srihari Gopal et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- A Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of 3 Doses of Paliperidone Palmitate in Adults With Acutely Exacerbated Schizophrenia
- (2010) Gahan J. Pandina et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophrenia
- (2010) S Gopal et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A Controlled, Evidence-Based Trial of Paliperidone Palmitate, A Long-Acting Injectable Antipsychotic, in Schizophrenia
- (2010) Henry A Nasrallah et al. NEUROPSYCHOPHARMACOLOGY
- A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia
- (2010) Gahan Pandina et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Profile of olanzapine long-acting injection for the maintenance treatment of adult patients with schizophrenia
- (2010) Rosaria rosaria di lorenzo Neuropsychiatric Disease and Treatment
- Long-acting injectable antipsychotics: focus on olanzapine pamoate
- (2010) Jean-Pierre Lindenmayer Neuropsychiatric Disease and Treatment
- Once-monthly paliperidone injection for the treatment of schizophrenia
- (2010) Delia Bishara Neuropsychiatric Disease and Treatment
- Population Pharmacokinetics of Intramuscular Paliperidone Palmitate in Patients with Schizophrenia
- (2009) Mahesh N. Samtani et al. CLINICAL PHARMACOKINETICS
- Practical guidance for dosing and switching paliperidone palmitate treatment in patients with schizophrenia
- (2009) S. Gopal et al. CURRENT MEDICAL RESEARCH AND OPINION
- Paliperidone palmitate - review of the efficacy, safety and cost of a new second-generation depot antipsychotic medication
- (2009) L. Citrome INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. Results of a randomized, double-blind, placebo-controlled efficacy and safety study
- (2009) Michelle Kramer et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Safety and tolerability of deltoid and gluteal injections of paliperidone palmitate in schizophrenia
- (2009) David Hough et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled study
- (2009) David Hough et al. SCHIZOPHRENIA RESEARCH
- Paliperidone for schizophrenia
- (2008) C. Dolder et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Paliperidone-ER: first atypical antipsychotic with oral extended release formulation
- (2008) Marion Lautenschlager et al. Expert Review of Neurotherapeutics
- Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost–effectiveness
- (2008) Samuel Keith Expert Review of Neurotherapeutics
- Paliperidone Extended-Release for the Treatment of Schizophrenia
- (2008) Jehan Marino et al. PHARMACOTHERAPY
- Partial compliance in schizophrenia and the impact on patient outcomes
- (2008) Pierre-Michel Llorca PSYCHIATRY RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More